Cargando…
What’s New in Critical Illness and Injury Science? Delirium, COVID-19, and critical illness
Autor principal: | Miller, Andrew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285128/ https://www.ncbi.nlm.nih.gov/pubmed/35845126 http://dx.doi.org/10.4103/ijciis.ijciis_44_22 |
Ejemplares similares
-
What's new in critical illness and injury science? Intravenous immunoglobulin for COVID-19 with severe or critical illness
por: Miller, Andrew C., et al.
Publicado: (2020) -
What’s New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium
por: Miller, Andrew C.
Publicado: (2023) -
What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness
por: Miller, Andrew Carl, et al.
Publicado: (2021) -
What's New in Critical Illness and Injury Science? A Look into Trauma Airway Management
por: Stahl, Jennifer L., et al.
Publicado: (2020) -
What's New in Critical Illness and Injury Science? Mortality effects of tocilizumab for patients admitted with COVID-19 pneumonia
por: Miller, Andrew C., et al.
Publicado: (2021)